Skip to main content

Table 4 Table showing the change in the log-likelihood of the models with added prognostic terms. Statistical significance of the change was determined by a likelihood ratio test

From: Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer

Variables

DFS

OS

∆LRχ2

P-value

∆LRχ2

P-value

CP +  PD-1 vs. CP

4.83

0.0280*

2.95

0.0856

CP +  PD-L1 vs. CP

5.22

0.0224*

3.95

0.0469*

CP +  CD274 vs. CP

3.66

0.0559

4.32

0.0378*

CP +  PDCD1 vs. CP

4.12

0.0425*

6.55

0.0105*

CP +  CD274  +  PDCD1 vs. CP

4.49

0.1057

6.12

0.0469*

CP +  PD-L1 + CD274 vs. CP

4.11

0.1278

7.02

0.0299*

CP +  PD-1+ + PDCD1 vs. CP

6.35

0.0417*

9.53

0.0085*

CP + CD8+PD-1+ vs. CP

7.53

0.0061*

3.16

0.0753

CP + IFNG vs. CP

7.50

0.0062*

5.29

0.0214*

  1. CP Clinicopathological parameters (patient age, tumor grade, tumor size and lymph node status), PD-1+ PD-1+ immune infiltrates (every 1 cell increment), PD-L1 PD-L1 tumor cell expression, LR Likelihood Ratio, CD8+PD-1+ CD8+PD-1+ T cells
  2. *Statistically significant